Abstract
The molecular revolution that is transforming the entire biomedical field has had far-reaching impact in its application to inherited human muscle disease. The gene for Duchenne muscular dystrophy was one of the first cloned without knowledge of the defective protein product. This success was based upon the availability of key chromosomal aberrations that provided molecular landmarks for the disease locus. Subsequent discoveries regarding the mode of expression for this gene, the structure and localization of its protein product dystrophin, and molecular diagnosis of affected and carrier individuals constitute a paradigm for investigation of human genetics. Finding the gene for myotonic muscular dystrophy is requiring the brute force approach of cloning several million bases of DNA, identifying expressed sequences, and characterizing candidate genes. The gene that causes hy-pertrophic cardiomyopathy has been found serendipitously to be one of the genetic markers on chromosome 14, the β myosin heavy chain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Epstein, H.F. 1990 Genetic analysis of myosin assembly in Caenorhab-ditis elegans. Mol. Neurobiol. in press.
Fyrberg, E. 1984. Study of contractile and cytoskeletal proteins using Drosophila genetics. Cell Motil. Cytoskel. 14: 118–127.
Waterston, R.H. 1989. Molecular genetic approaches to the study of motility in Caenorhabditis elegans. Cell Motil. Cytoskel. 14: 136–145.
Emery, A.E.H. 1987. Duchenne Muscular Dystrophy. Oxford University Press. New York.
Harper, P.S. 1979. Myotonic Dystrophy. Saunders. Philadelphia.
Boyd, Y. and Buckle, V.J. 1986. Cytogenetic heterogeneity of translocations associated with Duchenne muscular dystrophy. Clinical Genetics 29: 108–115.
Franke, U., Ochs, H., De Martinville, B., Giacalone, J., Lindgren, C., Disteche, C., Pagon, R.A., Hofker, M.H., Van Ommen, G.J.B., Pearson, P.L. and Wedgewood, R.J. 1985. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLoad syndrome. Am. J. Hum. Genet. 37: 250–267.
Ray, P.N., Belfall, B., Duff, C., Logan, C., Kean, V., Thompson, M.W., Sylvester, J.E., Gorski, J.L., Schimckel, R.D. and Worton, R.G. 1985. Cloning of the breakpoint of an Xp21 translocation associated with Duchenne muscular dystrophy. Nature 318: 672–675.
Hoffman, E.P. and Kunkel, L.M. 1989. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron 2: 1019–1029.
Worton, R.G. and Burghes, A.H.M. 1988. Molecular genetics of Duchenne and Becker muscular dystrophy. Int. Rev. Neurobiol. 29: 1–76.
Kohne, D.E., Levison, S.A. and Byers, M.J. 1977. Room temperature method for increasing the rate of DNA reassociation by many thousandfold: the phenol reassociation technique. Biochemistry 16: 5329–5341.
Kunkel, L.M., Monaco, A.P., Middlesworth, W., Ochs, H.D. and Latt, S.A. 1985. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc. Natl. Acad. Sci. USA 82: 4778–4782.
Monaco, A.P., Bertelson, C.J., Middlesworth, W., Colletti, C.A., Aldredge, J., Fischbeck, K.H., Bartlett, R., Pericak-Vance, M.A., Roses, A.D. and Kunkel, L.M. 1985. Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature 316: 840–845.
Monaco, A.P., Neve, R.L., Coletti-Feener, C., Bertelson, C.J., Kurnit, D.M. and Kunkel, L.M. 1986. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323: 646–650.
Koenig, M., Hoffman, E.P., Bertelson, C.J., Monaco, A.P., Feener, C. and Kunkel, L.M. 1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50: 509–517.
Mandel, J.L. 1989. The gene and its product. Nature 339: 584–586.
Van Ommen, G.J.B., Verkerk, J.M.H., Hofker, M.H., Monaco, A.P., Kunkel, L.M., Ray, P.N., Worton, R., Wieringa, B., Bakker, E. and Pearson, P.L. 1986. A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome. Cell 47: 499–504.
den Dunnen, J.T., Bakker, E., Klein-Breteler, E.G., Pearson, P.L. and van Ommen, G.J.B. 1987. Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature 329: 640–642.
Kunkel, L.M. et al. 1986. Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature 322: 73–77.
Forrest, S.M., Cross, G.S., Flint, T., Speer, A., Robson, K.J.H. and Davies, K.E. 1988. Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Genomics 2: 109–114.
Baumbach, L.L., Chamberlain, J.S., Ward, P.A., Farwell, N.J. and Caskey, C.T. 1989. Molecular and clinical correlations leading to Duchenne and Becker muscular dystrophies. Neurology 39: 465–474.
Kingston, H.M., Thomas, N.S.T., Pearson, P.L., Sarfarazi, M. and Harper, P.S. 1983. Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome. J. Med. Genet. 20: 255–258.
Kingston, H.M., Sarfarazi, M., Thomas, N.S.T. and Harper, P.S. 1984. Localization of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences. Hum. Genet. 67: 6–17.
Hart, K.A., Hodgson, S., Walker, A., Cole, C.G., Johnson, L., Dubowitz, V. and Bobrow, M. 1987. DNA deletions in mild and severe Becker muscular dystrophy. Hum. Genet. 75: 281–285.
Monaco, A.P., Bertelson, C.J., Liechti-Gallati, S., Moser, H. and Kunkel, L.M. 1988. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2: 90–95.
Malhotra, S.B., Hart, K.A., Klamut, H.J., Thomas, N.S.T., Bodrug, S.E., Burghes, A.H.M., Bobrow, M., Harper, P.S., Thompson, M.W., Ray, P.N. and Worton, R.G. 1988. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242: 755–759.
Hoffman, E.P., Fischbeck, K.H., Brown, R.H., Johnson, M., Medori, R., Loike, J.D., Harris, J.B., Waterston, R., Brooke, M., Specht, L., Kupsky, W., Chamberlain, J., Caskey, C.T., Shapiro, F. and Kunkel, L.M. 1988. Characterization of dystrophin in muscle-biopsy specimens from patient with Duchenne's or Becker's muscular dystrophy. New Engl. J. Med. 318: 1363–1368.
Koenig, M. et al. 1989. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet. 45: 498–506.
Gillard, E.F., Chamberlain, J.S., Murphy, E.G., Duff, C.L., Smith, B., Burghes, A.H.M., Thompson, M.W., Sutherland, J., Oss, I., Bodrug, S.E., Klamat, H.J., Ray, P.N. and Worton, R.G. 1989. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am. J. Hum. Genet. 45: 507–520.
Englund, S.B., Nicholson, L.V.B., Johnson, M.A., Forrest, S.M., Love, D.R., Zubrzycka-Gaarn, E.E., Bulman, D.E., Harris, J.B. and Davies, K.E. 1990. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343: 180–182.
Kazazian, H.H. and Boehm, C.D. 1988. Molecular basis and prenatal diagnosis of beta-thalassemia. Blood 72: 1107–1116.
Chamberlain, J.S., Pearlman, J.A., Muzny, D.M., Gibbs, R.A., Ranier, J.E., Reeves, A.A. and Caskey, C.T. 1988. Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science 239: 1416–1418.
Nudel, U., Robzyk, K. and Yaffe, D. 1988. Expression of the putative Duchenne muscular dystrophy gene in differentiated myogenic cell cultures and in the brain. Nature 331: 635–638.
Chelly, J., Kaplan, J.-C., Maire, P., Gautron, S. and Kahn, A. 1988. Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature 333: 858–860.
Nudel, U., Zuk, D., Einat, P., Zeelon, E., Levy, Z., Neuman, S. and Yaffe, D. 1989. Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature 337: 76– 78.
Feener, C.A., Koenig, M. and Kunkel, L.M. 1989. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature 338: 509–511.
Campbell, K.P. and Kahl, S.D. 1989. Association of dystrophin and an integral membrane glycoprotein. Nature 338: 259–262.
Koenig, M., Monaco, A.P. and Kunkel, L.M. 1988. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53: 219–228.
Davison, M.D. and Critchley, D.R. 1988. Alpha-spectrins and the DMD protein contain spectrin-like repeats. Cell 52: 159–160.
Watkins, S.C., Hoffman, E.P., Slayter, H.S. and Kunkel, L.M. 1988. Immunoelectron microscopic localization of dystrophin in myofibres. Nature 333: 863–866.
Hoffman, E.P., Brown, R.H. and Kunkel, L.M. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919–928.
Hoffman, E.P., Knudson, C.M., Campbell, K.P. and Kunkel, L.M. 1987. Subcellular fractionation of dystrophin to the triads of skeletal muscle. Nature 330: 754–758.
Hoffman, E.P., Watkins, S.C., Slayter, H.S. and Kunkel, L.M. 1989. Detection of a specific isoform of alpha-actinin with antisera directed against dystrophin. J. Cell Biol. 108: 503–510.
Bieber, F.R., Hoffman, R.P. and Amos, J.A. 1989. Dystrophin analysis in Duchenne muscular dystrophy: use in fetal diagnosis and in genetic counseling. Am. J. Hum. Genet. 45: 362–367.
Hoffman, E.P., Geggs, A.H., Koenig, M., Kunkel, L.M. and Ange-lini, C. 1989. Cross-reactive protein in Duchenne muscle. Lancet 333: 1211–1212.
Ginjaar, I.B., Bakker, E., den Dunnen, J.T., van Paassen, M.M.B., van Ommen, G.J.B., Zubrzycka-Gaarn, E., Kloosterman, M.D., Wessels, A. and Moorman, A.F.M. 1989. Immunological study of dystrophin in Duchenne fetus. Lancet 323: 1212–1213.
Nicholson, L.V.B., Davison, K., Johnson, M.A., Slater, C.R., Young, C., Bhattacharya, S., Gardner-Medwin, D. and Harris, J.B. 1989. Dystrophin in skeletal muscle II. Immunoreactivity in patterns with Xp21 muscular dystrophy. J. Neurol. Sci. 94: 137–146.
Love, D.R., Hill, D.F., Dickson, G., Spurr, N.K., Byth, B.C., Marsden, F.R., Walsh, F.S., Edwards, Y.H. and Davies, K.E. 1989. An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339: 55–58.
Hoffman, E.P., Hudecki, M.S., Rosenberg, P.A., Pollina, C.M. and Kunkel, L.M. 1988. Cell and fiber-type distribution of dystrophin. Neuron 1: 411–420.
Zubryzycka-Gaarn, E.E., Bulman, D.E., Karpati, G., Burghes, A.H.M., Belfall, B., Klamut, H.J., Talbot, J., Hodges, R.S., Ray, P.N. and Worton, R.G. 1988. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333: 466–469.
Bonilla, E., Samitt, C.E., Miranda, A.F., Hays, A.P., Salviati, G., DiMuaro, S., Kunkel, L.M., Hoffman, E.P. and Rowland, L.P. 1988. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 54: 447–452.
Eiberg, H., Mohr, J., Nielson, L.S. and Simonsen, N. 1982. Linkage relations between the locus for C3 and 50 polymorphic systems; assignment of C3 to the DM-Se-Lu linkage group; confirmation of C3-LES linkage; support of LES-DM synteny. Proc. IV Int. Cong. Hum. Genet. Jerusalem, 1981. Allan Liss, NY.
Eiberg, H., Mohr, J., Nielson, L.S., Simonsen, N. 1983. Genetics and linkage relationships of the C3 polymorphism: discovery of C3-Se linkage and assignment of LES-C3-DM-Se-PEPD-Lu synteny to chromosome 19. Clin. Genet. 24: 159–170.
Whitehead, A.S., Solomon, E., Chambers, S., Bodmer, W.F., Povey, S. and Fey, G. 1982. Assignment of the structural gene for the third component of human complement to chromosome 19. Proc. Natl. Acad. Sci. USA 79: 5021–5925.
Lusis, A.J., Heinzmann, C., Sparkes, R.S., Scott, J., Knott, T.J., Geller, R., Sparkes, M.C. and Mohandas, T. 1986. Regional mapping on human chromosome 19: organization of genes for plasma lipid transport (APOC1, C2, and E and LDLR) and the genes C3, PEPD and GPI. Proc. Natl. Acad. Sci. USA 83: 3929–3933.
Pericak-Vance, M.A., Yamaoka, L.H., Assinder, R.I.F., Hung, W.-Y., Bartlett, R.J., Stajich, J.M., Gaskell, P.C., Ross, D.A., Sherman, S., Fey, G.H., Humphries, S., Williamson, R. and Roses, A.D. 1986. Tight linkage of apotipoprotein C2 to myotonic dystrophy on chromosome 19. Neurology 36: 1418–1423.
Shaw, D.J., Meredith, A.L., Sarfarazi, M., Harley, H.G., Huson, S.M., Brook, J.D., Bufton, L., Litt, M., Mohandas, T. and Harper, P.S. 1986. Regional localizations and linkage relationships of seven RFLPs and myotonic dystrophy on chromosome 19. Hum. Genet. 74: 262–266.
Friedrich, U., Brunner, H., Smeets, D., Lambermon, E. and Ropers, H.-H. 1987. Three-point linkage analysis employing C3 and 19cen markers assigns the mvotonic dystrophy gene to 19q. Hum. Genet. 75: 291–293.
Nigro, J.M., Schweinfest, C.W., Rajkovid, A., Pavlovic, J., Jamal, S., Dottin, R.P., Hart, J.T., Kamarck, M.E., Rae, P.M.M., Carty, M.D. and Martin-DeLeon, P. 1987. cDNA cloning and mapping of the human creatine kinase M gene to 19ql3. Am. J. Hum. Genet. 40: 115–125.
Stallings, R.L., Olson, E., Strauss, A.W., Thompson, L.H., Bachinski, L.L. and Siciliano, M.J. 1988. Human creatine kinase genes on chromosome 15 and 19, and proximity of the gene for the muscle form to the genes for apolipoprotein C2 and excision repair. Am. J. Hum. Genet. 43: 144–151.
Shaw, D.J., Meredith, A.L., Sarfarazi, M., Huson, S.M., Brook, J.D., Myklebost, O. and Harper, P.S. 1985. The apolipoprotein CII gene: subchromosomal localization and linkage to the myotonic dystrophy locus. Hum. Genet. 70: 271–273.
Korneluk, R.G., MacKenzie, A.E., Nakamura, Y., Dube, I., Jacob, B. and Hunter, A.G.W. 1989. A reordering of human chromosome 19 long-arm DNA markers and identification of markers flanking the myotonic dystrophy locus. Genomics 5: 596–604.
Johnson, K., Shelbourne, P., Davies, J., Buxton, J., Nimmo, E., Anvret, M., Bonduelle, M., Williamson, B. and Savoutaus, M.-L. 1989. Recombination events that locate myotonic dystrophy distal to ApoC2 on 19q. Genomics 5: 746–751.
Schonk, D., Coerwinkel-Driessen, M., van Dalen, I., Oerlemans, F., Smeets, B., Schepens, J., Cockburn, D., Boyd, Y., Davis, M., Rettig, W., Shaw, D., Roses, A., Ropers, H. and Wieringa, B. 1989. Definition of subchromosomal intervals around the myotonic dystrophy gene region at 19q. Genomics 4: 384–396.
Brunner, H.G., Smeets, H., Lambermon, H.M.M., Coerwinkel- Driessen, M., van Oost, B.A., Wieringa, B. and Ropers, H.H. 1989. A multipoint linkage map around the locus for myotonic dystrophy on chromosome 19. Genomics 5: 589–595.
Smeets, H., Bachinski, L., Ceorwinkel, M., Schepens, J., Hoeijmakers, J., van Duin, M., Grzeschik, K.H., Weber, C.A., deJong, P., Siciliano, M.J. and Wieringa, B. 1990. A long range restriction map of the human chromosome 19ql3 region: close physical linkage between CKMM and the ERCC1 and ERCC2 genes. Am. J. Hum. Genet. 46: 492–501.
Johnson, K., Shelbourne, P., Davies, J., Nimmo, E., Buxton, J., Siciliano, M.J., Bachinski, L. L., Anvret, M., Harley, H., Rundle, S., Miki, T., Brunner, H. and Williamson, R. 1990. A new polymorphic marker which defines the region of chromosome 19 containing the myotonic dystrophy locus. Am. J. Hum. Genet. 46: 1073– 1081.
Yamaoka, L.H., Pericak-Vance, M.A., Gaskill, P.C., Stajich, J., Haynes, C., Hung, W.-Y., Laberge, C., Thibault, M.-C., Mathieu, J., Walker, A.P., Bartlett, R.J., Roses, A.D. 1990. Tight linkage of creatine kinase (CKMM) to myotonic dystrophy on chromosome 19. Neurology 40: 222–226.
Renaud, J.-F., Desnuelle, C., Schmid-Antomarchi, H., Hugues, M., Serratrice, G. and Lazdunski, M. 1986. Expression of apamin receptor in muscles of patients with myotonic muscular dystrophy. Nature 319: 678–680.
Jarcho, J.A., McKenna, W., Pare, J.A.P., Solomon, S.O., Holcombe, R.F., Dickie, S., Levi, T., Donis-Keller, H., Seidman, J.G. and Seidman, C.E. 1989. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14ql. New Engl. J. Med. 321: 1372– 1378.
Tanigawa, G., Jarcho, J.A., Kass, S., Solomon, S.D., Vosberg, H-P., Seidman, J.G. and Seidman, C.E. 1990. A molecular basis for familial hypertrophic cardiomyopathy: a cardiac α/β myosin heavy chain gene. Cell. 62: 991–998.
Geisterfer-Lowrance, A.A.T., Kass, S., Tanigawa, G., Vosbert, H.-P., McKenna, W., Seidman, J.G. and Seidman, C.E. 1990. A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain missense mutation. Cell. 62: 999–1006.
Epstein, H.F., Waterston, R.H. and Brenner, S. 1974. A mutant affecting the heavy chain of myosin in Caenorhabditis elegans. J. Mol. Biol. 90: 91–300.
O'Donnell, P.T. and Bernstein, S.I. 1988. Molecular and ultrastruc-tural defects in a Drosophila myosin heavy chain mutant: differential effects on muscle function produced by similar thick filament abnormalities. J. Cell Biol. 107: 2601–2612.
Ferrans, V.J., Morrow, A.G. and Roberts, W.C. 1972. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis: a study of operatively excised left ventricular outflow tract muscle in 14 patient. Circulation 45: 769–791.
Clark, C.E., Henry, W.L. and Epstein, S.E. 1973. Familial prevalence and genetic transmission of idiopathic subaortic stenosis. New Engl. J. Med. 289: 709–714.
Solomon, S.D., Jarcho, J.A., McKenna, W., Geisterfer-Lowrance, A., Germain, R., Salerni, R., Seidman, J.G. and Seidman, C. E. 1990. Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease. J. Clin. Invest. In press.
Ferraro, M., Scarton, G. and Ambrosini, M. 1990. Cosegregation of hypertrophic cardiomyopathy and a fragile site on chromosome 16 in a large Italian family. J. Med. Genet. 27: 363–366.
Darras, B.T., Koenig, M., Kunkel, L.M. and Franke, U. 1988. Direct method for prenatal diagnosis and carrier detection in Duchenne/ Becker muscular dystrophy using the entire dystrophin gene. Am. J. Med. Genet. 29: 713–726.
Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B. and Erlich, H.A. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymer-ase. Science 239: 487–491.
Chamberlain, J.S., Gibbs, R.A., Ranier, J.E., Nguyen, P.N. and Caskey, C.T. 1988. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 16: 1141–1156.
Hu, X., Burghes, A.H.M., Bulman, D.E., Ray, P.M. and Worton, R.G. 1989. Evidence for mutation by unequal sister chromatid exchange in the Duchenne muscular dystrophy gene. Am. J. Hum. Genet. 44: 855–863.
Arahata, K., Ishihara, T., Kamakura, K., Tsukahara, T., Ishiura, S., Baba, C., Matsumoto, T., Nonaka, I. and Sugita, H. 1989. Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy. New Engl. J. Med. 320: 138–142.
Ward, P.A., Hejtmancik, J.F., Witkowski, J.A., Baumbach, L.L., Gunnell, S., Speer, J., Hawley, P., Tantravahi, U., Caskey, C.T. and Latt, S. 1989. Prenatal diagnosis of Duchenne muscular dystrophy: prospective linkage analysis and retrospective dystrophin cDNA analysis. Am. J. Hum. Genet. 44: 270–281.
Partridge, T.A., Morgan, J.E., Coulton, G.R., Hoffman, E.P. and Kunkel, L.M. 1989. Conversion of mdx myofibres from dystrophin-negative to positive by injection of normal myoblasts. Nature 337: 176–179.
Wolff, J.A., Malone, R.W., Williams, P., Chong, W., Acsadi, G., Jani, A. and Feigner, P.L. 1990. Direct gene transfer into mouse muscle in vivo. Science 247: 1465–1468.
Law, P.K., Bertolini, T.E., Goodwin, T.G., Chen, M., Fang, Q., Li, H.-J., Kirby, D.S., Florendo, J.A., Herrod, H.G. and Golden, G.S. 1990. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 336: 114– 115.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dunne, P., Epstein, H. Molecular Biology of Human Muscle Disease. Nat Biotechnol 9, 41–46 (1991). https://doi.org/10.1038/nbt0191-41
Issue Date:
DOI: https://doi.org/10.1038/nbt0191-41